Erwin Schultz

4.4k citations

60 papers · 2.2k indexed · h-index 21

Impact in

Immunology top 2%
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
- Immune Cell Function and Interaction
Oncology top 5%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers

Papers in ⓘ

Dermatology 12
- Cutaneous lymphoproliferative disorders research 5
Immunology 26
- Immunotherapy and Immune Responses 22
- T-cell and B-cell Immunology 12
- Immune Cell Function and Interaction 5

Co-authors: Gerold Schuler (18 shared papers)Thomas Berger (7 shared papers)Pierre van der Bruggen (9 shared papers)Thierry Boon (7 shared papers)Pascal Chaux (4 shared papers)Vincent Stroobant (3 shared papers)Beatrice Schuler‐Thurner (5 shared papers)Jacques Chapiro (2 shared papers)
Journals: The Journal of Immunology (6 papers)American Journal of Potato Research (5 papers)JDDG Journal der Deutschen Dermatologischen Gesellschaft (2 papers)The Journal of Experimental Medicine (2 papers)International Journal of Cancer (2 papers)
Partner nations: Germany United States Belgium

In The Last Decade

Erwin Schultz

58 papers receiving 2.1k citations

Peers

Countries citing papers authored by Erwin Schultz

Since Specialization

Citations

This map shows the geographic impact of Erwin Schultz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erwin Schultz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erwin Schultz more than expected).

Fields of papers citing papers by Erwin Schultz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erwin Schultz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erwin Schultz. The network helps show where Erwin Schultz may publish in the future.

Co-authors

The 25 scholars most cited alongside Erwin Schultz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Erwin Schultz Line = papers co-authored together Erwin Schultz links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 60 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Rapid Induction of Tumor-specific Type 1 T Helper Cells in Metastatic Melanoma Patients by Vaccination with Mature, Cryopreserved, Peptide-loaded Monocyte-derived Dendritic Cells The Journal of Experimental Medicine ·Beatrice Schuler‐Thurner, Erwin Schultz, Thomas Berger, Georg Weinlich, Susanne Ebner, Petra Woerl, Armin Bender, Bernadette Feuerstein, Peter Fritsch, Nikolaus Romani, Gerold Schuler	2002	391
2	Tumor‐specific shared antigenic peptides recognized by human T cells Immunological Reviews ·Pierre van der Bruggen, Yi Zhang, Pascal Chaux, Vincent Stroobant, Christophe Panichelli, Erwin Schultz, Jacques Chapiro, Benoı̂t J. Van den Eynde, Francis Brasseur, Thierry Boon	2002	311
3	Artesunate in the treatment of metastatic uveal melanoma - first experiences Oncology Reports ·Thomas Berger, Detlef Dieckmann, Thomas Efferth, Erwin Schultz, Jens-Oliver Funk, Andreas S. Baur, Gerold Schuler	2005	149
4	Identification of Five MAGE-A1 Epitopes Recognized by Cytolytic T Lymphocytes Obtained by In Vitro Stimulation with Dendritic Cells Transduced with MAGE-A1 The Journal of Immunology ·Pascal Chaux, Rosalie M. Luiten, Nathalie Demotte, Valérie Vantomme, Vincent Stroobant, Catia Traversari, Vincenzo Russo, Erwin Schultz, Guy R. Cornelis, Thierry Boon, Pierre van der Bruggen	1999	129
5	A MAGE-A3 peptide presented by HLA-DP4 is recognized on tumor cells by CD4+ cytolytic T lymphocytes. PubMed ·Erwin Schultz, Bernard Lethé, C.L. Cambiaso, Jacques Van Snick, Pascal Chaux, Jurgen Corthals, Carlo Heirman, Kris Thielemans, Thierry Boon, Pierre van der Bruggen	2000	128
6	Generation of an Optimized Polyvalent Monocyte-Derived Dendritic Cell Vaccine by Transfecting Defined RNAs after Rather Than before Maturation The Journal of Immunology ·Niels Schaft, Jan Dörrie, Peter Thumann, Verena Beck, Ina Müller, Erwin Schultz, Eckhart Kämpgen, Detlef Dieckmann, Gerold Schuler	2005	115
7	The Production of a New MAGE-3 Peptide Presented to Cytolytic T Lymphocytes by HLA-B40 Requires the Immunoproteasome The Journal of Experimental Medicine ·Erwin Schultz, Jacques Chapiro, Christophe Lurquin, Stéphane Claverol, Odile Burlet‐Schiltz, Guy Warnier, Vincenzo Russo, Sandra Morel, Frédéric Lévy, Thierry Boon, Benoı̂t J. Van den Eynde, Pierre van der Bruggen	2002	99
8	T Cell Recognition of Desmoglein 3 Peptides in Patients with Pemphigus Vulgaris and Healthy Individuals The Journal of Immunology ·Christian Veldman, Kerstin Gebhard, Wolfgang Uter, Ralf Waßmuth, Joachim Grötzinger, Erwin Schultz, Michael Hertl	2004	93
9	Twelve-year survival and immune correlates in dendritic cell–vaccinated melanoma patients JCI Insight ·Stefanie Groß, Michael Erdmann, Ina Haendle, Steve Voland, Thomas Berger, Erwin Schultz, Erwin Strasser, Peter Dankerl, Rolf Janka, Stefan Schliep, Lucie Heinzerling, Karl Sotlar, Pierre G. Coulie, Gerold Schuler, Beatrice Schuler‐Thurner	2017	67
10	Antigen loading of dendritic cells with whole tumor cell preparations Journal of Immunological Methods ·Peter Thumann, Isabelle Moc, Jens Y. Humrich, Thomas Berger, Erwin Schultz, Gerold Schuler, Lars Jenne	2003	62
11	Immune checkpoint blockade with concurrent electrochemotherapy in advanced melanoma: a retrospective multicenter analysis Cancer Immunology Immunotherapy ·Markus V. Heppt, Thomas Eigentler, Katharina C. Kähler, Rudolf Herbst, Daniela Göppner, Thilo Gambichler, (unknown), Edgar Dippel, Carmen Loquai, Beatrice Schell, Bastian Schilling, Susanne G. Schäd, Erwin Schultz, Fanny Matheis, Julia K. Tietze, Carola Berking	2016	60
12	Functional Analysis of Tumor-Specific Th Cell Responses Detected in Melanoma Patients after Dendritic Cell-Based Immunotherapy The Journal of Immunology ·Erwin Schultz, Beatrice Schuler‐Thurner, Vincent Stroobant, Lars Jenne, Thomas Berger, Kris Thielemanns, Pierre van der Bruggen, Gerold Schuler	2004	54
13	Targeted combined anti-inflammatory and angiostatic therapy in advanced melanoma: a randomized phase II trial Melanoma Research ·Albrecht Reichle, Thomas Vogt, Brigitte Coras, Peter Terheyden, Klaus Neuber, Uwe Trefzer, Erwin Schultz, Anna Berand, E.‐B. Bröcker, Michael Landthaler, Reinhard Andreesen	2007	33
14	A MAGE‐3 peptide recognized on HLA‐B35 and HLA‐A1 by cytolytic T lymphocytes Tissue Antigens ·Erwin Schultz, Yi Zhang, R. W. Knowles, J A Tine, Catia Traversari, Thierry Boon, Pierre van der Bruggen	2001	33
15	Dendritic Cell-Based Immunotherapy Current topics in microbiology and immunology ·Thomas Berger, Erwin Schultz	2003	33
16	Afatinib-associated Stevens-Johnson syndrome in an EGFR-mutated lung cancer patient Lung Cancer ·Janine Doesch, Dirk Debus, Christian T. Meyer, Thomas Papadopoulos, Erwin Schultz, Joachim H. Ficker, Wolfgang M. Brueckl	2016	32
17	Pimecrolimus 1% Cream in the Treatment of Facial Psoriasis: A 16-Week Open-Label Study Dermatology ·Arnd Jacobi, Matthias Braeutigam, Vera Mahler, Erwin Schultz, Michael Hertl	2008	29
18	Cytokine gene transcription in renal cell carcinoma British journal of surgery ·Luis Filgueira, Markus Zuber, Adrian Merlo, Verena Caetano, Erwin Schultz, F. Harder, Giulio C. Spagnoli, M. Heberer	1993	25
19	Ex vivo analysis of desmoglein 1‐responsive T‐helper (Th) 1 and Th2 cells in patients with pemphigus foliaceus and healthy individuals Experimental Dermatology ·Kerstin Gebhard, Christian Veldman, Ralf Waßmuth, Erwin Schultz, Gerold Schuler, Michael Hertl	2005	23
20	A MAGE-1 peptide recognized on HLA-DR15 by CD4+ T cells European Journal of Immunology ·Pascal Chaux, Bernard Lethé, Jacques Van Snick, Jurgen Corthals, Erwin Schultz, C.L. Cambiaso, Thierry Boon, Pierre van der Bruggen	2001	22

About Erwin Schultz

Erwin Schultz is a scholar working on Dermatology, Immunology, Pathology and Forensic Medicine, Rheumatology and Oncology, having authored 60 papers that have together received 2.2k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (22 papers), T-cell and B-cell Immunology (12 papers), vaccines and immunoinformatics approaches (10 papers), Cancer Immunotherapy and Biomarkers (6 papers), Nonmelanoma Skin Cancer Studies (6 papers), Immune Cell Function and Interaction (5 papers), Autoimmune Bullous Skin Diseases (5 papers) and Cutaneous lymphoproliferative disorders research (5 papers). The work is most often cited by research in Immunology (1.5k citations), Oncology (756 citations), Molecular Biology (871 citations), Dermatology (104 citations) and Biotechnology (98 citations). Erwin Schultz has collaborated with scholars based in Germany, United States and Belgium. Frequent co-authors include Gerold Schuler, Thomas Berger, Pierre van der Bruggen, Thierry Boon, Pascal Chaux, Vincent Stroobant, Beatrice Schuler‐Thurner, Jacques Chapiro, Benoı̂t J. Van den Eynde and Yi Zhang. Their work appears in journals such as The Journal of Immunology, American Journal of Potato Research, JDDG Journal der Deutschen Dermatologischen Gesellschaft, The Journal of Experimental Medicine and International Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact